UNSPSC 51442720: Technetium Tc-99m teboroxime or technetium 99mtc teboroxime

This classification denotes a radioconjugate with the molecular formula (C6H9N2O2)2./C6H8N2O2.TC,CL,CH3,B, a cardiac imaging contrast medium most often used in myocardial perfusion imaging, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UT0WHJ4951, more generally known as Technetium Tc 99m teboroxime. In general, such compounds consist of one or more radioactive agents linked to a substance, and these in concert providing practitioners the ability to prevent, diagnose, or treat disease, especially cancer.

UNSPSC 51442720 Technetium Tc-99m teboroxime or technetium 99mtc teboroxime is a Commodity code that appears in state and local procurement records with minimal relevant recent activity. The two most recent opportunities posted under this code show little connection to the nominal scope — one involves maintenance services for Rapiscan X-ray inspection systems (airport security equipment), and the other covers bulk copper sulfate supply for water treatment or industrial use. Neither relates to technetium-based radiopharmaceuticals or medical imaging agents, the products the code name describes.

The mismatch between code designation and actual procurement suggests either miscoding in the source systems or that the code is not actively used for its intended scope in state and local markets. No opportunities targeting technetium-based pharmaceuticals, diagnostic imaging agents, or related clinical procurement appear in the recent record. State and local procurement of specialized medical radiopharmaceuticals typically flows through hospital systems, health departments, or coordinated group purchasing agreements rather than through open competitive solicitation, which may explain the disconnect between the code taxonomy and live market activity.